Financial PerformanceRevenue for Q2 was $8.8M, up 95% from the prior year and up 18% from the prior quarter, beating the Street's $8.1M estimate.
Product AdoptionMagic is now in use in 30% of the company's accounts compared to 20% in Q1, indicating increased adoption and positive physician feedback.
Regulatory ApprovalsThe July US clearance of Magic Sweep is a big regulatory achievement and should be followed by several more key US and EU approvals before year-end.